The Food and Drug Administration has warned that the blood pressure drug Olmesartan Medoxomil may cause a gastrointestinal condition known as sprue-like enteropathy. Used to treat patients with hypertension, Olmesartan Medoxomil is sold under the brand names Benicar, Benicar HCT, Azor, Tribenzor, and in generic form.
According to the FDA’s warning about Olmesartan Medoxomil, the symptoms of sprue-like enteropathy can include severe, chronic diarrhea and substantial weight loss. The agency has advised patients who experience persistent diarrhea or weight loss while taking Olmesartan Medoxomil for high blood pressure to contact their doctor, even if they have been taking the drug for several months or several years without previous symptoms.
Olmesartan Medoxomil is part of a class of drugs known as angiotensin II receptor blockers (ARBs) that can be prescribed by themselves or with other antihypertensive drugs to treat patients with high blood pressure. So far, olmesartan is the only ARB to be linked with sprue-like enteropathy.
Heygood, Orr & Pearson and Dangerous Drugs
If you or a loved one have been injured by dangerous drugs or other medical products, contact the lawyers at Heygood, Orr & Pearson to find out more about how we can help with your case.
For a free legal consultation and to find out more about whether you may be eligible to file a lawsuit, call us toll-free at 1-877-446-9001, or by filling out the free case evaluation form located at the top of this page.
Case results depend upon a variety of factors unique to each case. Results of other cases do not guarantee or predict a similar result in any future case.